###### Strengths and limitations of this study

-   This is the first study to our knowledge with a prospective, double-blinded design for the evaluation of chest wall tenderness on palpation in acute chest pain patients for ruling out acute coronary syndrome.

-   Our study supports data from previous studies that reproducible chest wall tenderness helps to rule out acute coronary syndrome in acute chest pain admissions.

-   Among the limitations are the small sample size and the possible interobserver and intraoberserver variability due to multiple study members and difficulty of standardising the index test.

Introduction {#s1}
============

Acute chest pain (ACP) accounts for approximately up to 10% of all medical emergency room admissions.[@R1] The estimated life time prevalence of ACP in the general population is 20--40%.[@R8] The spectrum of underlying conditions is broad and ranges from harmless musculoskeletal causes, gastro-oesophageal reflux disease, pneumonia, psychosomatic disorders to life-threatening conditions like pulmonary embolism, pneumothorax, aortic dissection and acute coronary syndrome (ACS). The reported incidence of ACS or angina pectoris in patients with ACP ranges between 4.8% and 12% in those seeking their general practitioners,[@R9] compared with up to 24% in patients presenting to University Hospital emergency units.[@R10]

In the diagnostic work-up of ACP, the medical history, clinical examination, laboratory tests, ECG and radiographic imaging are crucial to rapidly identify potentially life-threatening conditions such as ACS.[@R13] For example, ECG has a reported sensitivity between 20% and 60% for the diagnosis of ACS.[@R17] Laboratory results indicating myocardial ischaemia (troponin-I, troponin-T creatine kinase) may not be conclusive in the first hours after initiation of pain. This, therefore, mandates time-consuming serial laboratory tests.[@R17] Patients at low-to-intermediate risk with negative troponin, and normal or unclear ECG might have to undergo further testing like non-invasive cardiac imaging with radiation exposure.[@R18] [@R19] Such patients show more downstream testing like expensive invasive coronary angiography with additional radiation exposure and use of nephrotoxic radiographic contrast medium.[@R18] [@R20] [@R21]

Hence, it is desirable to have an early, fast and reliable bedside test to rule out ACS in patients presenting with ACP. Reproducible chest wall tenderness (CWT) on palpation of the thorax, where the maximum pain sensation is referred, is generally considered to be associated with a benign musculoskeletal cause and may help to rule out ACS in absence of additional examinations (ECG, laboratory tests, radiographic testing). Most of these studies were retrospective, in general practitioner settings, or the test was not clearly defined as one of the initial steps in the ACP evaluation process.[@R22] The exact diagnostic value of this sign has never been investigated in prospective and appropriately blinded clinical studies. To fill this lack of knowledge we aimed to evaluate, with a strict prospective and blinded design, the diagnostic performance of reproducible CWT as an easy bedside test to rule out early suspected ACS in emergency admissions presenting with ACP.

Methods {#s2}
=======

Participants {#s2a}
------------

Between July 2012 and December 2013, all consecutive patients referred by a third party or self-referred patients ≥18 years presenting with self-reported ACP (first or recurrent episode) at the emergency unit of the University Hospital Zurich were prospectively included in this study when a member of the study team was present. Exclusion criteria were recent thoracic surgery within 1 year, any chronic inflammatory joint or connective tissue disease, fibromyalgia and unstable haemodynamic condition with systolic blood pressure ≤90 mm Hg or tachyarrhythmia. Furthermore, patients referred directly to the cardiac chest pain unit by a third party or for whom laboratory results, ECG or chest X-ray were already available at the time of enrolment were excluded.

Written informed consent was obtained from all patients. The study was registered at <http://www.clinicaltrials.gov> (NCT01724996).

Index test {#s2b}
----------

The index test is reproducible CWT on palpation. Patients were brought into supine position with 30° elevated upper body. Flat digital index with moderate pressure was applied, where the maximum pain was pointed by the patient. 'Reproducible CWT' or 'non-reproducible CWT' was noted.

Presence of reproducible CWT was defined as the following: the self-reported pain could be provoked in the same quality and intensity by digital palpation over the region of complaints over the chest. If no pain or any other pain than the self-reported pain by palpation could be elicited, the test result was defined as non-reproducible CWT.

Reference test {#s2c}
--------------

ACS was defined according to the universal definition of acute myocardial infarction in the ESC Guidelines from 2012.[@R26]The gold standard reference tests to rule out ACS in patients with ACP are serial troponin measurements and/or ECG.[@R27]

Study course in the emergency unit {#s2d}
----------------------------------

After admission to the emergency unit, the first assessment and triage of patients with ACP was conducted by an attending physician or nurse not related to the study team to check for haemodynamic stability and for the need of urgent medical care. After enrolment, an investigator of the study performed the index test. Index test of CWT was noted before completing the standardised questionnaire (see below), and further initial routine clinical diagnostics, including medical history, physical examination, ECG, laboratory testing and chest X-ray, were initiated by a study-independent emergency physician. At the time of chest palpation, the investigator was blinded for the final diagnosis, which was made by another emergency physician independent of the study team, based on the initial diagnostic work-up and possible further examinations (eg, coronary angiography, CT).

Questionnaire and data collection {#s2e}
---------------------------------

Intensity of ACP was graded with the visual analogue scale (VAS) ranging from 0 (no pain) to 10 (worst pain). Localisation of maximum pain (retrosternal, left or right chest side), pain radiation (right arm, left arm, neck, back or epigastric), quality of pain (stabbing, pressure, burning or squeezing), pain aggravating and relieving factors (respiration, movements or rest), and additional symptoms (dyspnoea, nausea, vertigo, sweating) were asked. Moreover, it was noted whether ACP was a first episode or recurrent episode, and if the patient was self-referred or referred by a third party. Previous coronary artery disease (CAD), cardiovascular risk factors (arterial hypertension, dyslipidaemia, obesity, family history, diabetes mellitus, smoking status), illicit drug use, alcohol consumption, medication and demographic data were registered.

Statistical analysis {#s2f}
--------------------

All statistical analyses were performed using IBM SPSS Statistics for Windows, V.22 (IBM Corporation, Armonk, New York, USA). Data are reported as median±IQR from 25th to 75th centile or mean±SD or percentages, as appropriate. Continuous variables were analysed using the Student t test or Mann-Whitney U test, as appropriate. Categorical data were analysed with χ^2^ test or Fisher's exact test, respectively. p Values of all outcomes were two-sided; a value less than 0.05 was considered to indicate statistical significance. CI was defined as 95%. Furthermore, diagnostic sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), likelihood ratio (LR) and OR of reproducible CWT for ruling in or ruling out ACS were analysed. Multivariable logistic regression analysis was applied to investigate the independent association between ACS and CWT, controlling for established cardiovascular risk factors (known CAD, age, sex, arterial hypertension, dyslipidaemia, family history of CAD, smoking and diabetes). Goodness-of-fit of the model was tested using Hosmer-Lemeshow χ^2^ test.

Results {#s3}
=======

Participants {#s3a}
------------

A total of 121 patients (median age 47 years, IQR 34--66.5 years, 60.3% male) were included in the study. In total, 71.1% of patients were self-referrals. In 52.9% of patients, the ACP was the first episode. Demographic data and cardiovascular risk profile of all emergency admissions with ACP and categorised as ACS and non-ACS are summarised in [table 1](#BMJOPEN2014007442TB1){ref-type="table"}. Patients in the ACS group were significantly older and cardiovascular risk factors (dyslipidaemia and hypertension) were more prevalent. In [figure 1](#BMJOPEN2014007442F1){ref-type="fig"} the self-reported localisation of the maximum ACP sensation is shown.

###### 

Baseline characteristics of all emergency admissions with ACP

                                       All emergency admissions with ACP   ACS                      Non-ACS                  p Value
  ------------------------------------ ----------------------------------- ------------------------ ------------------------ -----------
  N                                    121                                 14 (11.6%)               107 (88.4%)              
  Gender (male)                        73 (60.3%)                          10 (71.4%)               63 (58.87%)              0.56
  Age \[years\]                        47 \[34--66.5\]                     61.0 \[54.5--66.3\]      45.0 \[34.0--68\]        **0.011**
  BMI (kg/m^2^)                        27.0 \[24.4--29.7\]                 27.0 \[25.7--30.0\]      27.0 \[23.9--29.6\]      0.268
  Systolic blood pressure \[mm Hg\]    132.5 \[122.0--143.50\]             144.5 \[133.0--154.8\]   130.5 \[121.0--141.0\]   **0.014**
  Diastolic blood pressure \[mm Hg\]   81 \[76.0--90\]                     90 \[80.0--100.0\]       80 \[75.0--89.3\]        **0.031**
  Heart rate (\*/min)                  75 \[66.0--88.0\]                   76 \[63.8--85.0\]        75 \[66--88\]            0.784
  VAS (0--10)                          5.0 \[4.0--7.0\]                    5 \[2.0--7.3\]           5 \[4--7\]               1.0
  Previous medication:                                                                                                       
   Antihypertensive medication         36 (29.8%)                          6 (42.9%)                28 (28.0%)               0.35
   Analgesic medication                25 (20.7%)                          3 (21.4%)                22 (20.6%)               1.00
   Anticoagulants                      31 (25.6%)                          6 (42.9%)                25 (23.4%)               0.19
  Alcohol abuse                        33 (27.5%)                          8 (57.1%)                25 (23.4%)               **0.021**
  Illicit drug abuse                   8 (6.6%)                            0                        8 (7.5%)                 0.59
  Smoker                               43 (35.5%)                          5 (35.7%)                38 (35.5%)               1.0
  Cigarettes consumption \[PY\]        7.21 (±14.9)                        10.0 (±16.1)             6.9 (±14.8)              0.67
  Hypertension                         47 (38.8%)                          11 (78.6%)               36 (33.6%)               **0.002**
  Known CAD                            18 (14.9%)                          2 (14.3%)                16 (15.0%)               1.0
  Dyslipidaemia                        33 (27.3%)                          8 (57.1%)                25 (23.4%)               **0.021**
  Family history positive for CAD      37 (30.6%)                          7 (50.0%)                30 (28.0%)               0.123
  Diabetes mellitus                    6 (5.0%)                            0                        6 (5.6%)                 1.0

Bold typeface indicates significant results.

(±), SD; \[\], IQR; ACP, acute chest pain; ACS, acute coronary syndrome; BMI, body mass index; CAD, coronary artery disease; PY, pack years; VAS, visual analogue scale.
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The characterisation of symptoms on emergency room admission is displayed in [table 2](#BMJOPEN2014007442TB2){ref-type="table"}. The self-reported chest pain in the ACS group was localised mainly retrosternal, and described as pressure compared with patients without ACS who had stabbing pain on the left side with aggravation on deep inspiration.

###### 

Characterisation of symptoms on emergency room admission

                             ACS (n=14)   Non-ACS (n=107)   p Value
  -------------------------- ------------ ----------------- ---------
  Pain localisation                                         
   Retrosternal              11 (78.6%)   33 (30.8%)        \<0.001
   Left chest                3 (21.4%)    65 (60.8%)        0.008
   Right chest               0            8 (7.5%)          0.59
   Epigastric                0            1 (0.9%)          1.0
  Pain character                                            
   Stabbing                  3 (21.4%)    61 (57.0%)        0.02
   Pressure                  9 (64.3%)    33 (30.8%)        0.01
   Burning                   2 (14.3%)    6 (5.6%)          0.23
   Squeezing                 0            7 (6.5%)          1.0
  Pain radiation                                            
   No radiation              4 (28.6%)    52 (48.6%)        0.25
   Left arm                  5 (35.7%)    24 (22.4%)        0.31
   Right arm                 3 (21.4%)    9 (8.4%)          0.14
   Jaw                       1 (7.1%)     5 (4.7%)          0.52
   Back                      1 (7.1%)     13 (12.1%)        1.0
   Epigastric                0            4 (3.7%)          1.0
  Pain alleviating factors                                  
   No                        9 (64.3%)    51 (49.0%)        0.24
   Respiration               0            3 (2.9%)          1.0
   Movement                  0            7 (6.7%)          1.0
   Rest                      5 (35.7%)    46 (44.2%)        0.78
  Pain aggravating factors                                  
   No                        6 (42.9%)    40 (37.37%)       0.77
   Respiration               1 (7.1%)     41 (38.38%)       0.03
   Movement                  6 (42.9%)    25 (23.23%)       0.19
   Rest                      1 (7.1%)     1 (1.01%)         0.22
  Additional symptoms                                       
   No                        6 (42.9%)    60 (57.7%)        0.40
   Dyspnoea                  5 (35.7%)    24 (23.1%)        0.32
   Nausea                    0            7 (6.7%)          1.0
   Dizziness                 2 (14.2%)    9 (8.7%)          0.61
   Sweating                  1 (7.1%)     7 (6.7%)          1.0

ACS, acute coronary syndrome.

### Final diagnosis {#s3a1}

The leading cause of ACP was a musculoskeletal disorder (62, 51.2%) after other diagnoses had been excluded ([table 3](#BMJOPEN2014007442TB3){ref-type="table"}). In 14 (11.6%) patients, of whom the large majority were men, based on troponin and/or ECG changes the final diagnosis of ACS could be made. Thirteen patients were treated with percutaneous coronary intervention using drug-eluting stents while one was referred for urgent coronary artery bypass surgery ([figure 2](#BMJOPEN2014007442F2){ref-type="fig"}).

###### 

Final diagnosis after emergency unit admission with acute chest pain

  Diagnosis                           Total (N=121)
  ----------------------------------- ---------------
  Musculoskeletal disorder            62 (51.2%)
  Acute coronary syndrome             14 (11.6%)
  Gastro-oesophageal reflux disease   6 (5.0%)
  Pneumonia                           6 (5.0%)
  Tachyarrhythmia                     7 (5.8%)
  Perimyocarditis                     6 (5.0%)
  Pulmonary embolism                  5 (4.1%)
  Stable angina pectoris              5 (4.1%)
  Pleuritis                           3 (2.5%)
  Hypertensive emergency              3 (2.5%)
  Psychosomatic disorder              3 (2.5%)
  Aortic dissection                   1 (0.8%)

![Enrolment and outcomes of ACP admissions and CWT test. ACP, acute chest pain; ACS, acute coronary syndrome; CWT, chest wall tenderness.](bmjopen2014007442f02){#BMJOPEN2014007442F2}

In [figure 2](#BMJOPEN2014007442F2){ref-type="fig"} the flow chart of enrolment and outcomes of CWT test in ACP admissions is shown.

### Index test 'CWT' versus reference test 'troponin and/or ECG' versus 'troponin' {#s3a2}

Based on the reference test of troponin and/or ECG, 14 out of 121 were classified as patients with ACS. Fifty-three of the 121 patients had reproducible CWT. In 13 of the 14 patients with ACS, CWT was non-reproducible resulting in a sensitivity of 92.9%; 52 out of 107 patients without ACS had reproducible CWT resulting in a specificity of 48.6%. Only 1 out of 53 patients with reproducible CWT suffered from ACS resulting in a NPV of 98.1%. In contrast, 13 out of the 68 patients with non-reproducible CWT suffered from ACS resulting in a PPV of 19.1%. Serial troponin measurements showed a sensitivity of 85.7% and specificity of 86.9%, PPV of 46.2% and NPV for 97.9% for ACS ([tables 4](#BMJOPEN2014007442TB4){ref-type="table"} and [5](#BMJOPEN2014007442TB5){ref-type="table"}) compared with the reference test of troponin and/or ECG.

###### 

Reproducible chest wall tenderness in patients with and without ACS

                         ACS (n=14)   Non-ACS (n=107)   p Value
  ---------------------- ------------ ----------------- ---------
  Non-reproducible CWT   13 (92.8%)   55 (51.4%)        0.003
  Reproducible CWT       1 (7.1%)     52 (48.6%)        

ACS, acute coronary syndrome; CWT, chest wall tenderness.

###### 

Diagnostic performance of 'non-reproducible CWT' and 'troponin' for the diagnosis of acute coronary syndrome

                Non-reproducible CWT   Serial troponin                                     
  ------------- ---------------------- ----------------- ------- ------- ----------------- -------
  Sensitivity   92.9%                  66.1% to 98.8%    0.003   85.7%   57.2 to 97.8%     0.000
  Specificity   48.6%                  38.8% to 58.5%            86.9%   79.0% to 92.65%   
  PPV           19.1%                  10.6% to 30.5%            46.2%   26.61% to 66.1%   
  NPV           98.1%                  89.9% to 99.7%            97.9%   92.6% to 99.7%    
  Positive LR   1.8                    1.4 to 2.3                6.6     3.8 to 11.2       
  Negative LR   0.15                   0.02 to 2.3               0.16    0.05 to 0.6       
  OR                                   1.6 to 97.3       0.017   39.9    8.1 to 197.2      0.000

CWT, chest wall tenderness; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.

Non-reproducible CWT remained independently associated with ACS after correction for known CAD, age, gender, family history of CAD, arterial hypertension, smoking, diabetes and dyslipidaemia resulting in an adjusted OR of 7.5 (95% CI 1.4 to 40.1; p=0.018). The model showed no evidence of lack of fit based on the Hosmer-Lemeshow χ^2^ statistic.

Discussion {#s4}
==========

Clinical examination, including palpation of the chest wall, is part of the routine evaluation of patients with ACP. Reproducible CWT in patients presenting with ACP may be associated with a benign cause like musculoskeletal disorders and may help to rule out ACS.[@R22] [@R23] In our prospective study in the emergency department of the University Hospital Zurich, we evaluated the diagnostic performance of CWT on palpation to rule out ACS in patients presenting with ACP. Non-reproducible CWT had a high sensitivity, low specificity and low PPV for the diagnosis of ACS. However, the presence of reproducible CWT helped to rule out ACS with a high NPV. The results of this prospective, double-blinded study are consistent with other findings in retrospective analyses with different patient cohorts and settings. A recent cross-sectional study carried out by general physicians showed that reproducible CWT in patients presenting with chest pain had an adjusted OR in a multivariate model of 0.27 for the diagnosis of CAD. Corresponding positive LR and negative LR for the presence of CWT for excluding and including CAD were 0.25 and 1.71, respectively.[@R8] According to meta-analysis data, reproducible CWT had, compared with our study, a similar sensitivity (3--15%) and specificity (64--83%) for the diagnosis of ACS. In reproducible CWT, positive LR was 0.3, and in non-reproducible CWT, negative LR increases to 1.3 suggesting that reproducible CWT is negatively associated with ACS.[@R24] Similar results were published in the meta-analysis by Bruyninckx *et al* who reported a 94% sensitivity of non-reproducible CWT for the diagnosis of ACS. Negative LR in the setting of non-reproducible CWT was 0.17.[@R25] In another cross-sectional study, a prediction score in patients with ACP and underlying possible CAD was proposed for general practitioners. Aside from other five variables (age, gender, known vascular disease, 'patient thinks heart is causing the pain', exercise-dependent pain), 'pain not reproducible on palpation' was an independent determinant for the prediction of a CAD. Non-reproducible CWT on palpation had an adjusted OR of 3.15.[@R28] In our study sample, we could detect reproducible CWT as an independent determinant to rule out ACS after correction for the established cardiovascular risk factors in a multivariate model with an OR of 7.5, which is consistent with the data from Chun and McGee.[@R24] Our study results also confirm the data analysed by Goodacre *et al*[@R17] who stated that non-reproducible CWT had a sensitivity of 91.7%, low specificity of 27.8%, PPV of 4.2%, NPV of 99.0%, positive LR of 1.27 and negative LR of 0.30 for the diagnosis of ACS. However, in most of the publications, the quality of CWT was not clearly defined. Furthermore, the sequence of the clinical evaluation was not clearly defined and it is not evident if the investigator or patient was already informed about further test results or differential diagnoses.[@R22] To address these issues, we designed our study as strictly prospective enabling the blinding of patient and investigator for the primary end point. We conducted CWT as an initial step showing that reproducible CWT as a fast bedside test helped to rule out ACS in a very early stage. Moreover, we only considered reproducible CWT (ie, pain triggered by palpation corresponds exactly to the self-reported ACP). CWT of alternative quality was excluded and registered as non-reproducible CWT. The important new finding of our study is that only reproducible CWT helps to rule out ACS and not any CWT. Interestingly our index test 'non-reproducible CWT' had a similar sensitivity and NPV compared with the reference test of serial troponin measurements for ruling out ACS in ACP. However, serial troponin analysis is time consuming compared with the fast and easy CWT test. Nevertheless, troponin is highly specific, thus resulting in better PPV for the diagnosis of ACS.[@R29] Regarding the secondary end points, ACP in ACS group was mainly reported retrosternal, pressure-like and less stabbing like that which is consistent with previous studies.[@R23] [@R30] Deep inspiration as pain aggravating factor was significantly more reported in the non-ACS group, most probably due to underlying musculoskeletal disorder, pleuritis or perimyocarditis.

Limitations {#s5}
===========

Albeit the members of the study team were blinded for the final diagnosis, the physical appearance of the patients (eg, body mass index, gender, age) could have biased the physician. Furthermore, the applied pressure for testing of CWT is not standardised, which may have led to interobserver and intraobserver variability. Using a dolorimeter[@R31] could help to minimise this bias. However, the aim of the study was to investigate a simple bedside test and a dolorimeter is not applicable in daily clinical practice. Another limitation was that patient enrolment was only carried out when a member of the study team was present. Also of note is that the ACS group in our study population was too small to evaluate other predictive factors for the diagnosis of ACS, including aspects of the patient\'s history and pain characteristics in multivariate analysis. The subgroup analysis considering age, gender, socioeconomic status, pre-existing conditions would also require a greater sample size. Nevertheless, a subgroup analysis concerning the impact of these factors on CWT would be of great interest as there is evidence for differences in pain perception in different age groups, gender, socioeconomic status and in patients with comorbidities.[@R32] These subgroup studies might have implications for clinicians in dealing with patients presenting with ACP.

Conclusion {#s6}
==========

This first prospective, double-blinded diagnostic study shows that palpation of the chest wall is a fast and easy feasible bedside test in patients presenting with ACP. If reproducible CWT is present, the test helps to rule out ACS at an early stage of the diagnostic process. However, ACS or other diagnoses should be considered in patients with non-reproducible CWT. It goes without saying that testing of CWT does not replace a thorough history taking, and clinical and further diagnostic evaluation. However, this study demonstrates that palpation of the chest wall should be performed *as a first step* in ACP admissions to improve early triage and decision-making until ECG and troponin tests are available. Larger studies are needed to confirm these findings.
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